Calcipotriol zur Prävention der Polymorphen Lichtdermatose - Calcipotriol und PLD
- Conditions
- Polymorphic light eruptionMedDRA version: 9.1Level: LLTClassification code 10036087Term: Polymorphic light eruption
- Registration Number
- EUCTR2008-000626-39-AT
- Lead Sponsor
- Medizinische Universität Graz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Patients with Polymorphous light eruption
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
skin cancer,
malignant melanoma,
multiple dysplastc nevi,
photosensitive disorders,
autoimmune diseases,
therapy with immunosuppressive drugs,
liver or renal diseases,
pregnancy and nursing,
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To investigate the efficacy of a pretreatment with calcipotriol in polymorphic light eruption.;Secondary Objective: ;Primary end point(s): PLD Score
- Secondary Outcome Measures
Name Time Method